Limited replication of influenza A virus in human mast cells

Immunologic Research

Volumn 56, Issue 1, 2013, Pages 32-43

  Marcet, Candy W ^a   St Laurent, Chris D ^a   Moon, Tae Chul ^a   Singh, Nav ^a   Befus, A Dean ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Antiviral; Hemagglutinin; Influenza A; Innate immunity; Mast cell; Myxovirus

Indexed keywords

HEMAGGLUTININ; VIRUS RNA;

ARTICLE; CELL COUNT; CELL VIABILITY; CONTROLLED STUDY; EPITHELIUM CELL; HEMADSORPTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; INFLUENZA VIRUS A; INNATE IMMUNITY; MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA REPLICATION; SYNTHESIS; ULTRAVIOLET RADIATION; VIRUS ATTACHMENT; VIRUS INACTIVATION; VIRUS RELEASE; VIRUS REPLICATION; VIRUS TRANSCRIPTION; WESTERN BLOTTING;

CELLS, CULTURED; EPITHELIAL CELLS; HUMANS; IMMUNITY, INNATE; INFLUENZA A VIRUS; INFLUENZA, HUMAN; LUNG; MAST CELLS; RNA, VIRAL; TRANSCRIPTION, GENETIC; VIRION; VIRUS REPLICATION;

EID: 84876416458     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-012-8377-4     Document Type: Article

References (42)

1. Rothberg MB, Haessler SD, Brown RB. Complications of viral influenza. Am J Med. 2008;121(4):258-64.
2. Julkunen I, Melen K, Nyqvist M, Pirhonen J, Sareneva T, Matikainen S. Inflammatory responses in influenza A virus infection. Vaccine. 2000;19(Suppl 1):S32-7.
3. Wang JP, Kurt-Jones EA, Finberg RW. Innate immunity to respiratory viruses. Cell Microbiol. 2007;9(7):1641-6.
4. Boyce JA. Mast cells: beyond IgE. J Allergy Clin Immunol. 2003;111(1):24-32; quiz 3.
5. Galli SJ, Maurer M, Lantz CS. Mast cells as sentinels of innate immunity. Curr Opin Immunol. 1999;11(1):53-9.
6. Marshall JS. Mast-cell responses to pathogens. Nat Rev Immunol. 2004;4(10):787-99.
7. Sundstrom JB, Ellis JE, Hair GA, Kirshenbaum AS, Metcalfe DD, Yi H, et al. Human tissue mast cells are an inducible reservoir of persistent HIV infection. Blood. 2007;109(12):5293-300.
8. Clementsen P, Bisgaard H, Pedersen M, Permin H, Struve-Christensen E, Milman N, et al. Staphylococcus aureus and influenza A virus stimulate human bronchoalveolar cells to release histamine and leukotrienes. Agents Actions. 1989;27(1-2):107-9.
9. Dietrich N, Rohde M, Geffers R, Kroger A, Hauser H, Weiss S, et al. Mast cells elicit proinflammatory but not type I interferon responses upon activation of TLRs by bacteria. Proc Natl Acad Sci USA. 2010;107(19):8748-53.
10. St. John AL, Rathore AP, Yap H, Ng ML, Metcalfe DD, Vasudevan SG et al. Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc Natl Acad Sci USA. 2011;108(22):9190-5.
11. Hu Y, Jin Y, Han D, Zhang G, Cao S, Xie J, et al. Mast cell-induced lung injury in mice infected with H5N1 influenza virus. J Virol. 2012;86(6):3347-56.
12. King CA, Marshall JS, Alshurafa H, Anderson R. Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J Virol. 2000;74(15):7146-50.
13. King CA, Anderson R, Marshall JS. Dengue virus selectively induces human mast cell chemokine production. J Virol. 2002;76(16):8408-19.
14. Brown MG, McAlpine SM, Huang YY, Haidl ID, Al-Afif A, Marshall JS, et al. RNA sensors enable human mast cell anti-viral chemokine production and IFN-mediated protection in response to antibody-enhanced dengue virus infection. PLoS ONE. 2012;7(3):e34055.
15. Kulka M, Alexopoulou L, Flavell RA, Metcalfe DD. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol. 2004;114(1):174-82.
16. Yan N, Chen ZJ. Intrinsic antiviral immunity. Nat Immunol. 2012;13(3):214-22.
17. Kirshenbaum AS, Akin C, Wu Y, Rottem M, Goff JP, Beaven MA, et al. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk Res. 2003;27(8):677-82.
18. Sekar Y, Moon TC, Slupsky CM, Befus AD. Protein tyrosine nitration of aldolase in mast cells: a plausible pathway in nitric oxide-mediated regulation of mast cell function. J Immunol. 2010;185(1):578-87.
19. Kirshenbaum AS, Goff JP, Semere T, Foster B, Scott LM, Metcalfe DD. Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood. 1999;94(7):2333-42.
20. Moon TC, Lee E, Baek SH, Murakami M, Kudo I, Kim NS, et al. Degranulation and cytokine expression in human cord blood-derived mast cells cultured in serum-free medium with recombinant human stem cell factor. Mol Cells. 2003;16(2):154-60.
21. Yoshimura T, Moon TC, St Laurent CD, Puttagunta L, Chung K, Wright E et al. Expression of nitric oxide synthases in leukocytes in nasal polyps. Ann Allergy Asthma Immunol. 2012;108(3):172-7.
22. Duta V, Duta F, Puttagunta L, Befus AD, Duszyk M. Regulation of basolateral Cl(-) channels in airway epithelial cells: the role of nitric oxide. J Membr Biol. 2006;213(3):165-74.
23. Cottey R, Rowe CA, Bender BS. Influenza virus. Curr Protoc Immunol. 2001;Chapter 19:Unit 19 1.
24. Gaush CR, Smith TF. Replication and plaque assay of influenza virus in an established line of canine kidney cells. Appl Microbiol. 1968;16(4):588-94.
25. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg. 1938;27:493-7.
26. Brown EG, Bailly JE. Genetic analysis of mouse-adapted influenza A virus identifies roles for the NA, PB1, and PB2 genes in virulence. Virus Res. 1999;61(1):63-76.
27. Manicassamy B, Manicassamy S, Belicha-Villanueva A, Pisanelli G, Pulendran B, Garcia-Sastre A. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci USA. 2010;107(25):11531-6.
28. Cassidy LF, Lyles DS, Abramson JS. Synthesis of viral proteins in polymorphonuclear leukocytes infected with influenza A virus. J Clin Microbiol. 1988;26(7):1267-70.
29. Lee SM, Dutry I, Peiris JS. Editorial: macrophage heterogeneity and responses to influenza virus infection. J Leukoc Biol. 2012;92(1):1-4.
30. Ioannidis LJ, Verity EE, Crawford S, Rockman SP, Brown LE. Abortive replication of influenza virus in mouse dendritic cells. J Virol. 2012;86(10):5922-5.
31. Ye ZP, Pal R, Fox JW, Wagner RR. Functional and antigenic domains of the matrix (M1) protein of influenza A virus. J Virol. 1987;61(2):239-46.
32. Ye ZP, Baylor NW, Wagner RR. Transcription-inhibition and RNA-binding domains of influenza A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides. J Virol. 1989;63(9):3586-94.
33. Baudin F, Petit I, Weissenhorn W, Ruigrok RW. In vitro dissection of the membrane and RNP binding activities of influenza virus M1 protein. Virology. 2001;281(1):102-8.
34. Kaiser L, Fritz RS, Straus SE, Gubareva L, Hayden FG. Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol. 2001;64(3):262-8.
35. Hayden FG, Treanor JJ, Fritz RS, Lobo M, Betts RF, Miller M, et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA. 1999;282(13):1240-6.
36. Li Y, Li L, Wadley R, Reddel SW, Qi JC, Archis C, et al. Mast cells/basophils in the peripheral blood of allergic individuals who are HIV-1 susceptible due to their surface expression of CD4 and the chemokine receptors CCR3, CCR5, and CXCR4. Blood. 2001;97(11):3484-90.
37. Burke SM, Issekutz TB, Mohan K, Lee PW, Shmulevitz M, Marshall JS. Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism. Blood. 2008;111(12):5467-76.
38. Dakhama A, Lee YM, Ohnishi H, Jing X, Balhorn A, Takeda K et al. Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice. J Allergy Clin Immunol. 2009;123(1):138-45.
39. Marshall JS, King CA, McCurdy JD. Mast cell cytokine and chemokine responses to bacterial and viral infection. Curr Pharm Des. 2003;9(1):11-24.
40. Shirato K, Taguchi F. Mast cell degranulation is induced by A549 airway epithelial cell infected with respiratory syncytial virus. Virology. 2009;386(1):88-93.
41. Artuc M, Steckelings UM, Grutzkau A, Smorodchenko A, Henz BM. A long-term coculture model for the study of mast cell-keratinocyte interactions. J Invest Dermatol. 2002;119(2):411-5.
42. Hsieh FH, Sharma P, Gibbons A, Goggans T, Erzurum SC, Haque SJ. Human airway epithelial cell determinants of survival and functional phenotype for primary human mast cells. Proc Natl Acad Sci USA. 2005;102(40):14380-5.